4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-24-031108
Options or other derivatives
- Chief Medical Officer acquired 152,345 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | 2024-03-01 | Grant or award · Restricted Stock Units | +105,470 | 105,470 | D: show line 1 in the form | |||||
| GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | 2024-03-01 | Grant or award · Restricted Stock Units | +46,875 | 46,875 | D: show line 2 in the form |
Loading xslF345X05/tm248017-4_4seq1.xml…